Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 318
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06652971 | A Clinical Trial to Evaluate the Food Effect of CKD-379 | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT03051841 | CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT03034486 | The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 | ||
| NCT04867720 | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients | ||
| NCT05347576 | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions | ||
| NCT04521023 | A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy | ||
| NCT02977065 | To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors | ||
| NCT03738449 | The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition | ||
| NCT03414840 | Assessment of Change in Atherosclerotic Plaque by Serial CCTA | ||
| NCT02064556 | CKD-330 Drug-Drug Interaction Study (Amlodipine) | ||
| NCT01340248 | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers | ||
| NCT04673864 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 | ||
| NCT05245084 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg | ||
| NCT04224350 | Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) | ||
| NCT01030679 | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus | ||
| NCT02627027 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers | ||
| NCT02247505 | CKD-397 Drug-drug Interaction Study (B) | ||
| NCT05952219 | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 | ||
| NCT02589457 | Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet | ||
| NCT03770052 | Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie | ||
| NCT02827890 | CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) | ||
| NCT05657574 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia | ||
| NCT01106131 | Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin | ||
| NCT04651881 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT01991145 | Allogeneic UCB Therapy With EPO in Children With CP | ||
| NCT04906798 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions | ||
| NCT02586311 | CKD-330 Phase 3 Trial in Amlodipine Non-responder | ||
| NCT04539652 | Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients | ||
| NCT01860482 | The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD | ||
| NCT05834595 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 | ||
| NCT03726853 | The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance | ||
| NCT02801526 | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A | ||
| NCT04830930 | A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers | ||
| NCT03583905 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet | ||
| NCT04223895 | A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers | ||
| NCT01842269 | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients | ||
| NCT01341392 | Drug-drug Interaction Study(CKD-501, Amlodipine) | ||
| NCT04857177 | A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration | ||
| NCT02300467 | NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors | ||
| NCT06386328 | A Clinical Trial to Evaluate the Food Effect of CKD-378 | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes | ||
| NCT05881707 | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg | ||
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
| NCT04511000 | Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg | ||
| NCT04627207 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of CKD-333 and D085 in Healthy Volunteers | ||
| NCT03431623 | CKD-11101 Phase 3 SC Study |
